Evaluating the total costs of chemotherapy-induced toxicity: Results from a pilot study with ovarian cancer patients

Keyphrases

• Neurotoxicity 100%
• Ovarian Cancer Patients 100%
• Chemotherapy Toxicity 100%
• Neutropenia 80%
• Thrombocytopenia 80%
• Indirect Costs 80%
• Chemotherapy 40%
• Caregivers 40%
• Direct Medical Costs 40%
• Cancer Costs 40%
• Hospitalization 20%
• Cancer Patients 20%
• Medical Care 20%
• Patient Activity 20%
• Activities of Daily Living 20%
• Hematotoxicity 20%
• Cancer-related 20%
• Toxicity Study 20%
• Medical Devices 20%
• Physician Visits 20%
• Cost Estimation 20%
• Data Cost 20%
• Phone Calls 20%
• Home Visits 20%
• Productivity Loss 20%
• Lost Productivity 20%
• Caregiver Support 20%
• Labor Force 20%
• Cost Information 20%
• Out-of-pocket 20%
• Toxicity Estimation 20%
• Job Loss 20%
• Supportive Cancer Care 20%
• Hospital Accounting 20%
• Accounting Data 20%
• Comprehensive Cost 20%
• Laboratory Physician 20%
• Resource Estimates 20%
• Labor Employment 20%
• Labor Earnings 20%
• Force Employment 20%

Nursing and Health Professions

• Pilot Study 100%
• Thrombocytopenia 100%
• Ovary Cancer 100%
• Neutropenia 100%
• Neurotoxicity 100%
• Malignant Neoplasm 50%
• Health Economics 50%
• Medical Device 25%
• Hospital Cost 25%
• House Call 25%
• Cancer Care 25%
• Health Care 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Neutropenia 100%
• Chemotherapy 100%
• Neurotoxicity 100%
• Ovary Cancer 100%
• Thrombocytopenia 100%
• Malignant Neoplasm 75%